Liposomal bupivacaine for open urological surgery: Friend or foe?
Urol Oncol
.
2021 May;39(5):306-307.
doi: 10.1016/j.urolonc.2021.02.006.
Epub 2021 Feb 18.
Authors
Jaasmit Khurana
1
,
Adrian S Fairey
2
,
Niels-Erik Jacobsen
2
,
Vivian Hy Ip
3
Affiliations
1
Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton, AB, Canada.
2
Division of Urology, Department of Surgery, University of Alberta Hospital, Edmonton, AB, Canada.
3
Department of Anesthesiology and Pain Medicine, University of Alberta Hospital, Edmonton, AB, Canada. Electronic address: hip@ualberta.ca.
PMID:
33610445
DOI:
10.1016/j.urolonc.2021.02.006
No abstract available
Publication types
Letter
Comment
MeSH terms
Bupivacaine*
Humans
Pain, Postoperative*
Substances
Bupivacaine